The mutual relationship between the host immune system and radiotherapy: stimulating the action of immune cells by irradiation

• Published in: International journal of clinical oncology Vol. 28; no. 2; pp. 201 - 208
• Main Authors: Watanabe, Tsubasa, Sato, Genki Edward, Yoshimura, Michio, Suzuki, Minoru, Mizowaki, Takashi
• Format: Journal Article
• Language: English
• Published: Singapore Springer Nature Singapore 01.02.2023; Springer Nature B.V
• Subjects: Antigens; Antigens, Neoplasm; Antitumor activity; Cancer Research; Combined Modality Therapy; Effector cells; Humans; Immune checkpoint inhibitors; Immune Checkpoint Inhibitors - therapeutic use; Immune response; Immune system; Immune System - pathology; Immune System - radiation effects; Immunity; Immunocompromised hosts; Immunotherapy; Invited Review Article; Medicine; Medicine & Public Health; Neoplasms - drug therapy; Oncology; Radiation therapy; Radiotherapy; Surgical Oncology; Tumor Microenvironment; Tumors; Radiosensitivity; Radiotherapy; Immune cells; Cancer-immunity cycle
• ISSN: 1341-9625; 1437-7772
• DOI: 10.1007/s10147-022-02172-2

The effects of irradiation on tumor tissue and the host immune system are interrelated. The antitumor effect of irradiation is attenuated in the immunocompromised hosts. In addition, radiation alone positively and negatively influences the host immune system. The positive effects of radiation are summarized by the ability to help induce and enhance tumor–antigen-specific immune responses. The cancer-immunity cycle is a multistep framework that illustrates how the tumor–antigen-specific immune responses are induced and how the induced antigen-specific immune cells exert their functions in tumor tissues. Irradiation affects each step of this cancer-immunity cycle, primarily in a positive manner. In contrast, radiation also has negative effects on the immune system. The first is that irradiation has the possibility to kill irradiated effector immune cells. The second is that irradiation upregulates immunosuppressive molecules in the tumor microenvironment, whereas the third is that irradiation to the tumor condenses immunosuppressor cells in the tumor microenvironment. When used in conjunction with radiotherapy, immune checkpoint inhibitors can further leverage the positive effects of radiation on the immune system and compensate for the negative effects of irradiation, which supports the rationale for the combination of radiotherapy and immune checkpoint inhibitors. In this review, we summarize the preclinical evidence for the reciprocal effects of radiation exposure and the immune system, and up-front topics of the combination therapy of immune checkpoint inhibitors and radiotherapy.